ORKA fund manager activity
Oruka Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q3 2025 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | New | 67,874 | $6,459,567 | 0.00% | Aug 4, 2026 |
| Viking Global Investors | Trimmed | 1,503,478 | $143,086,001 | 0.41% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Viking Global Investors | No change | 2,666,690 | $130,801,145 | 0.37% | May 15, 2026 |